An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing buyers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Worries
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in individuals administering substances of unknown origin.
Some professionals said the demand for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, risking fines, legal action or imprisonment.
Service Response and Content Removal
According to the social media company, the service has taken down problematic content and prohibited related keywords and search suggestions. The company stated it was committed to keeping the service safe and investing in enhancing compliance measures.
Digital Trading Activities
Research also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of users, populated with photos of weight loss, positive testimonials and step-by-step instructions for mixing or administering at residence.
After moments of joining one community, a vendor shared contact information, where most transactions take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or previous experience.
Product Details and Pricing
Inside these communities, posts show black plastic parcels with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram stated it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering materials they cannot confirm. Although the research behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has already seen patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially significant health risks”.
